A groundbreaking annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully ...

Data from a very early-phase trial shows that the drug is safe and remains in the body for up to 56 weeks. From two ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

We can now prevent HIV transmissions and deaths — progress impossible without investments from the U.S. government ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

Global efforts to tackle the HIV/AIDS epidemic continue to remain insufficient, with deadly consequences, the UN Human Rights ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

Mizoram has recorded the highest prevalence of the HIV in India, standing at 2.73 percent which surpasses the national average of 0.2 percent, according to reports.